These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11754737)

  • 1. Adenovirus vector-mediated reporter system for in vivo analyses of human CYP3A4 gene activation.
    Furukawa M; Okubo T; Ogino M; Yamazaki T; Shimada M; Nagata K; Yamazoe Y
    J Biochem; 2002 Jan; 131(1):71-8. PubMed ID: 11754737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reporter gene assay to assess the molecular mechanisms of xenobiotic-dependent induction of the human CYP3A4 gene in vitro.
    Ogg MS; Williams JM; Tarbit M; Goldfarb PS; Gray TJ; Gibson GG
    Xenobiotica; 1999 Mar; 29(3):269-79. PubMed ID: 10219967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo activation of the human CYP3A4 promoter in mouse liver and regulation by pregnane X receptors.
    Zhang W; Purchio A; Chen K; Burns SM; Contag CH; Contag PR
    Biochem Pharmacol; 2003 Jun; 65(11):1889-96. PubMed ID: 12781341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A transgenic mouse model with a luciferase reporter for studying in vivo transcriptional regulation of the human CYP3A4 gene.
    Zhang W; Purchio AF; Chen K; Wu J; Lu L; Coffee R; Contag PR; West DB
    Drug Metab Dispos; 2003 Aug; 31(8):1054-64. PubMed ID: 12867495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes.
    Barwick JL; Quattrochi LC; Mills AS; Potenza C; Tukey RH; Guzelian PS
    Mol Pharmacol; 1996 Jul; 50(1):10-6. PubMed ID: 8700101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of human pregnane X receptor involvement in pesticide-mediated activation of CYP3A4 gene.
    Matsubara T; Noracharttiyapot W; Toriyabe T; Yoshinari K; Nagata K; Yamazoe Y
    Drug Metab Dispos; 2007 May; 35(5):728-33. PubMed ID: 17293382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Putative role of the orphan nuclear receptor SXR (steroid and xenobiotic receptor) in the mechanism of CYP3A4 inhibition by xenobiotics.
    Takeshita A; Taguchi M; Koibuchi N; Ozawa Y
    J Biol Chem; 2002 Sep; 277(36):32453-8. PubMed ID: 12072427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system.
    Raucy J; Warfe L; Yueh MF; Allen SW
    J Pharmacol Exp Ther; 2002 Oct; 303(1):412-23. PubMed ID: 12235278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways.
    Cerveny L; Svecova L; Anzenbacherova E; Vrzal R; Staud F; Dvorak Z; Ulrichova J; Anzenbacher P; Pavek P
    Drug Metab Dispos; 2007 Jul; 35(7):1032-41. PubMed ID: 17392393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marmoset CYP3A21, a model for human CYP3A4: protein expression and functional characterization of the promoter.
    Koehler SC; Von Ahsen N; Schlumbohm C; Asif AR; Goedtel-Armbrust U; Oellerich M; Wojnowski L; Armstrong VW
    Xenobiotica; 2006 Dec; 36(12):1210-26. PubMed ID: 17162468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of four naturally occurring variants of human pregnane X receptor (PXR): one variant causes dramatic loss of both DNA binding activity and the transactivation of the CYP3A4 promoter/enhancer region.
    Koyano S; Kurose K; Saito Y; Ozawa S; Hasegawa R; Komamura K; Ueno K; Kamakura S; Kitakaze M; Nakajima T; Matsumoto K; Akasawa A; Saito H; Sawada J
    Drug Metab Dispos; 2004 Jan; 32(1):149-54. PubMed ID: 14709632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a reporter gene assay to predict and rank the potency and efficacy of CYP3A4 inducers.
    El-Sankary W; Gibson GG; Ayrton A; Plant N
    Drug Metab Dispos; 2001 Nov; 29(11):1499-504. PubMed ID: 11602528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azole antimycotics differentially affect rifampicin-induced pregnane X receptor-mediated CYP3A4 gene expression.
    Svecova L; Vrzal R; Burysek L; Anzenbacherova E; Cerveny L; Grim J; Trejtnar F; Kunes J; Pour M; Staud F; Anzenbacher P; Dvorak Z; Pavek P
    Drug Metab Dispos; 2008 Feb; 36(2):339-48. PubMed ID: 17998298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes.
    Liddle C; Goodwin BJ; George J; Tapner M; Farrell GC
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2411-6. PubMed ID: 9661620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simultaneous assessment of CYP3A4 metabolism and induction in the DPX-2 cell line.
    Trubetskoy O; Marks B; Zielinski T; Yueh MF; Raucy J
    AAPS J; 2005 Mar; 7(1):E6-13. PubMed ID: 16146350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor.
    Faucette SR; Sueyoshi T; Smith CM; Negishi M; Lecluyse EL; Wang H
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1200-9. PubMed ID: 16513849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells.
    Schuetz JD; Schuetz EG; Thottassery JV; Guzelian PS; Strom S; Sun D
    Mol Pharmacol; 1996 Jan; 49(1):63-72. PubMed ID: 8569713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening.
    Hartig PC; Bobseine KL; Britt BH; Cardon MC; Lambright CR; Wilson VS; Gray LE
    Toxicol Sci; 2002 Mar; 66(1):82-90. PubMed ID: 11861975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Approaches to Study Regulation of Hepatic Cytochrome P450 (CYP) 3A Expression by Paclitaxel and Rifampicin.
    Ghose R; Mallick P; Taneja G; Chu C; Moorthy B
    Methods Mol Biol; 2016; 1395():55-68. PubMed ID: 26910068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro drug-induced hepatotoxicity screening system using CYP3A4-expressing and gamma-glutamylcysteine synthetase knockdown cells.
    Hosomi H; Akai S; Minami K; Yoshikawa Y; Fukami T; Nakajima M; Yokoi T
    Toxicol In Vitro; 2010 Apr; 24(3):1032-8. PubMed ID: 19958826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.